Skip to main content
Log in

Effect of indoramin on finger blood flow in vasospastic patients

  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effect of indoramin on blood pressure, heart rate and finger blood flow was investigated in eleven patients with essential acrocyanosis. Indoramin 50 mg t. i. d. and placebo were administered for 6 weeks, in random order in a double blind, cross-over trial. In 8 of the 11 patients, finger blood flow, measured by venous occlusion plethysmography was higher and resistance was lower with indoramin. There was no significant change in blood pressure or heart rate. Thus, indoramin may be useful when a decrease in alpha-adrenoreceptor tone in the fingers is desirable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Shepherd, J. T.: The physiology of blood flow in the limbs. In: Peripheral Vascular Diseases, p. 63–78, W. B. Saunders 1972

  2. Coffman, J. D., Davies, W. T.: Vasospastic diseases: A review. Prog. Cardiovasc. Dis.18, 123–146 (1975)

    Google Scholar 

  3. Clement, D. L., Pannier, R.: Influence de l'indoramine sur la circulation cutanée chez les sujets vasospastiques. Schweiz. Rund. f. Med.65, 1435–1436 (1976)

    Google Scholar 

  4. Alps, B. J., Hill, M., Johnson, E. S., Wilson, A. B.: Quantitative analysis on isolated organs of the autonomic blocking properties of indoramin hydrochloride (Wy 21 901). Br. J. Pharmacol.44, 52–62 (1972)

    Google Scholar 

  5. Whitney R. J.: The measurement of volume changes in human limbs. J. Physiol.212, 1–27 (1953)

    Google Scholar 

  6. Coltart, D. J., Lockhardt, J. D. F., Royds, R. B., Turner, P.: Human pharmacology of indoramin. Br. J. Pharmacol.43, 467 P (1971)

    Google Scholar 

  7. Boakes, A. I., Prichard, B. N. C., Teoh, P. C.: Alpha-adrenoreceptor inhibition from indoramin in man. Br. J. Pharmacol.44, 378 P (1972)

    Google Scholar 

  8. Lewis, P. J., George, C. F., Dollery, C. T.: Clinical evaluation of indoramin, a new antihypertensive agent. Europ. J. clin. Pharmacol.6, 211–216 (1973)

    Google Scholar 

  9. Royds, R. B., Lockhardt, J. D. F.: The effect of indoramin on peripheral blood flow. Br. J. clin. Pharmacol.1, 13–17 (1974)

    Google Scholar 

  10. Fares, C. M., Milliken, J. C.: The effect of parenteral indoramin on peripheral blood flow in patients with Raynaud's disease or atherosclerosis associated intermittent claudication. Curr. Med. Res.2, 57–62 (1974)

    Google Scholar 

  11. Draffan, G. H., Lewis, P. J., Firmin, J. L., Jordan, T. W., Dollery, C. T.: Pharmacokinetics of indoramin in man. Br. J. Pharmacol.3, 489–495 (1976)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clement, D.L. Effect of indoramin on finger blood flow in vasospastic patients. Eur J Clin Pharmacol 14, 331–333 (1978). https://doi.org/10.1007/BF00611902

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00611902

Key words

Navigation